Oral anticoagulant monotherapy significantly reduces major bleeding compared to combined therapy in stable coronary artery disease
Anticoagulant alone may cut bleeding risk in heart patients
This meta-analysis of randomized controlled trials involving 5924 patients found that oral anticoagulant monotherapy results in a comparable…
For some heart patients, skipping aspirin and using only an anticoagulant may lower bleeding risk without raising heart risks.
OAC monotherapy offers optimal balance for secondary prevention in atrial fibrillation and stroke patients compared to combination strategies
Taking one blood thinner alone works best for heart and stroke patients compared to mixing medicines
A network meta-analysis of 14,104 patients suggests oral anticoagulant monotherapy is the most favorable strategy for secondary prevention i…
Doctors found that using just one blood thinner is safer and more effective than mixing it with other pills. This approach lowers stroke ris…